Debu Tripathy

A New Era in Small Cell Lung Cancer Treatment

September 11, 2024

Article

Dr. Debu Tripathy, editor-in-chief of CURE magazine, discusses the advancements made in small cell lung cancer.

Minimal Residual Disease Remains An Evolving and Game-Changing Field

September 06, 2023

Article

MRD testing began among patients with chronic myeloid leukemia, a disease that lends itself to gauging MRD because it is driven by a specific genetic mutation.

A Step Forward in Treating KRAS G12-Mutated Lung Cancer

April 18, 2022

Article

Activating mutations in this class of oncogenes, specifically KRAS, have made a big step forward scientifically and clinically just in the last couple of years.

Some Immunity Is Better Than None Against COVID-19

March 20, 2022

Article

Many things can influence a patient’s response to the COVID-19 vaccine, such as their treatments or whether they have a higher tumor burden.